Black Rock Inc. Cyclo Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Cyclo Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 59,510 shares of CYTH stock, worth $42,847. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,510

Previous 37,126 60.29%

Holding current value

$42,847

Previous $51,000 47.06%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.16 - $1.53 $25,965 - $34,247	22,384 Added 60.29%	59,510 $75,000
Q1 2024 May 10, 2024	SELL	$1.39 - $1.9 $15,732 - $21,504	-11,318 Reduced 23.36%	37,126 $51,000
Q4 2023 Feb 13, 2024	BUY	$0.93 - $1.88 $44,716 - $90,394	48,082 Added 13282.32%	48,444 $77,000
Q2 2022 Aug 12, 2022	SELL	$1.97 - $3.21 $35,146 - $57,269	-17,841 Reduced 98.01%	362 $1,000
Q1 2022 May 12, 2022	BUY	$2.62 - $4.51 $11,402 - $19,627	4,352 Added 31.42%	18,203 $58,000
Q4 2021 Feb 10, 2022	BUY	$3.47 - $7.34 $2,487 - $5,262	717 Added 5.46%	13,851 $51,000
Q3 2021 Nov 09, 2021	BUY	$6.21 - $10.04 $14,220 - $22,991	2,290 Added 21.12%	13,134 $88,000
Q2 2021 Aug 11, 2021	BUY	$6.58 - $10.85 $71,353 - $117,657	10,844 New	10,844 $111,000

Others Institutions Holding CYTH

# of Institutions

Shares Held

749K

Call Options Held

Put Options Held

Epiq Capital Group, LLC San Francisco, CA

689K
Shares

$496,401
0.11% of portfolio

View Full List

About Cyclo Therapeutics, Inc.

Ticker CYTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 8,439,440
Market Cap $6.08M
Description
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of...

More about CYTH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account